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There Must Be 50 Ways to Rule Minireview
the Signal: The Case of the
Drosophila EGF Receptor
Norbert Perrimon* and Lizabeth A. Perkins² development raises the question of how one RTK regu-
lates each of these developmental processes.*Department of Genetics
One answer is that there are multiple Egfr ligands thatHoward Hughes Medical Institute
activate the RTK in a tissue-specific manner. Character-Harvard Medical School
ization of mutants that exhibit only a subset of the EgfrBoston, Massachusetts 02115
mutant phenotypes led to the identification of three can-²Pediatric Surgical Research Laboratories
didate Egfr ligands, Spitz (Spi; Rutledge et al., 1992),Massachusetts General Hospital
Gurken (Grk; reviewed by Ray and Schupbach, 1996)Boston, Massachusetts 02114
and Vein (Vn; Schnepp et al., 1996). All three proteins
contain an EGF repeat similar to that of transforming
growth factor (TGF)-a, a known ligand of the vertebrateOne common route by which extracellular signals regu-
EGF RTK.late gene expression isvia activationof receptortyrosine
Two scenarios have emerged by which these ligandskinase (RTK) signaling pathways. The processes regu-
activate the Egfr. In the case of Grk, at one point duringlated by these receptors and their ligands are diverse
oogenesis, grk transcripts become localized to theand include the regulation of cell growth, differentia-
antero-dorsal corner of the oocyte resulting in the pro-tion, migration, viability, and homeostasis. Interestingly,
duction of a spatially restricted ligand, which presum-while some RTKs are cell type specific and devoted
ably is secreted into the perivitelline space and activatesto a single specific function, others are implicated in
Egfr in the adjacent dorsal follicle cells (reviewed by Raymultiple processes (reviewed by Perrimon, 1994). In Dro-
and Schupbach, 1996).sophila, single function RTKs include Sevenless (Sev),
In contrast, Spi is uniformly expressed (Rutledge etwhich specifies the differentiation of one photoreceptor
al., 1992), suggesting that an additional level of regula-in the adult eye, and Torso (Tor), utilized exclusively for
tion must be involved to explain how Spi activates Egfrdetermination of cell fates at both embryonic termini. In
in a tissue-specific manner. Characterization of Spi incontrast, the Drosophila epidermal growth factor (EGF)
tissue culture has revealed that it is produced as a trans-RTK (Egfr) is involved in a myriad of developmental deci-
membrane precursor which is processed into a secretedsions; just in the embryo, Egfr is involved in theestablish-
form (Schweitzer et al., 1995a). The ubiquitous naturement of ventral cell fates, maintenance of amnioserosa
of Spi expression suggests a model whereby one orand ventral neuroectodermal cells, germ band retrac-
more factors required for Spi processing must be spa-tion, cell fate specification in the central nervous system,
tially restricted to specify where Spi is processed, se-and production of cuticle.
creted, and subsequently activates Egfr.A few years ago, the examination of RTK signaling
Golembo et al. (1996b) obtained evidence for such apathways culminated with the realization that most
model by examining Egfr signaling in the embryonic
RTKs regulate p21ras activity, which subsequently acti-
ventral ectoderm. During embryogenesis, it has been
vates a kinase cascade that sequentially involves Raf,
proposed that graded Egfr signaling patterns the ventral
MEK, and MAPK (see Perrimon, 1994). Central to the
ectoderm with highest activity defining the ventral-most
establishment of this ªuniversal cassetteº dogma were epidermal cell fates. In both Egfr and spi mutant em-
studies of the single function Drosophila RTKs (Sev and bryos, defects in dorso-ventral (D/V) patterning are ob-
Tor) that provided excellent genetic paradigms to iden- served. The signal that triggers graded activation of Egfr
tify molecules involved in transduction of the signals, appears to originate from the ventral midline since in
as well as to characterize their relative positions within single minded (sim) mutant embryos, where the ventral
the signaling cascade. Recently, a number of studies midline does not develop, patterning of ectodermal cells
have focused on understanding how a single RTK, such along the D/V axis is abnormal and exhibits a nearly
as Egfr, can regulate multiple developmental responses. identical ventral ectodermal mutant phenotype as spi.
In this review, we discuss how a multiplicity of ligands, Golembo et al. (1996b) found that the production of
positive and negative tissue specific feedback loops, secreted Spi only in the ventral midline was able to
and cooperativity between different RTKs offer a diverse rescue ventral ectodermcell fates of spi mutantembryos
array of strategies to regulate the actions of the same suggesting that localized processing of Spi at the mid-
receptor. Many of these mechanisms will likely be con- line organizes the graded activation of Egfr. To demon-
served during evolution; therefore, it is anticipated that strate that secreted Spi is the only factor essential for
critical lessons learned by examination of Drosophila ventral ectoderm determination that is produced by the
Egfr signaling will contribute significantly to our under- midline, Golembo et al. (1996b) ectopically expressed
standing of vertebrate RTK signaling. the secreted form of Spi in the ectoderm of sim mutant
Multiple Ligands Regulate Egfr Function embryos. In this case, secreted Spi not only induces
During Development ventral cell fates but also gives rise to ventralized em-
In addition to its multiple functions during embryogene- bryos. Together, these results provide compelling evi-
sis (listed above), Egfr activity, which correlates with its dence that Spi acts as a processed, secreted ligand;
broad expression pattern, is critical for proliferation of however, it remains to be shown that a processed form
imaginal tissues, and in the determination of both the of Spi exists in vivo.
antero-posterior and dorso-ventral polarities of the oo- The third putative Egfr ligand, Vn, is expressed in
highly dynamic patterns that are consistent with thecyte. The seemingly global requirement of Egfr during
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embryonic mutant phenotypes of Egfr (Schnepp et al.,
1996). For example, beginning at blastoderm stages, vn
transcripts are expressed as two broad ventro-lateral
stripes in cells patterned by the Efgr. Although vn mutant
embryos only exhibit weak D/V patterning defects, ge-
netic evidence that Vn operates in Egfr signaling stems
from embryos doubly mutant for null alleles of both spi
and vn that exhibit more severe mutant phenotypes than
spi mutant embryos alone. This finding suggests that
Spi cooperates with Vn in establishing the gradient of
Egfr activity during embryogenesis, thus illustrating the
possibility that multiple ligands operate in concert for
proper spatial and temporal activation of Egfr.
Interestingly, the embryonic phenotype of spi; vn dou-
ble mutants is not as severe as the Egfr null mutant
phenotype, suggesting that a basal, ligand-independent
Egfr activity exists, or that a third, unknown ligand regu-
lates Egfr during embryogenesis, or that maternally pro-
vided Spi activity masks the interaction.
The processing of Spi from an inactive to an active
form is in apparent contrast to Vn and possibly Grk. Vn
contains, inaddition to the EGF repeat, an Ig-like domain
with homology to the neuregulins and lacks a transmem-
brane domain (Schnepp et al., 1996). The mechanism
by which Vn is processed, if at all, is not understood.
Grk encodes a potential transmembrane domain but it
has not yet been determined whether Grk functions as
an unprocessed, membrane-localized signal or is pro-
cessed into a secreted active ligand. Figure 1. Egfr Signaling Pathway
Collectively, the studies on the candidate Egfr ligands
have revealed that one of the mechanisms by which
or processing of the transmembrane form of Spi. EctopicEgfr activity can be modulated is by the existence of
expression of rho only in the ventral midline of rho mu-multiple ligand activities. Diversity in the expression pat-
tant embryos is sufficient to rescue the ectodermal de-terns of these ligands as well as in the molecular mecha-
fects observed in these animals, suggesting that Rhonisms deployed to activate them have increased the
function is required in the midline where it acts nonau-repertoire of functions of this RTK.
tonomously to pattern the ventral ectoderm (Golembo etRegulation of Egfr Activity by Positive
al., 1996b). In addition, another transmembrane protein,and Negative Feedback Loops
Star (S), behaves similarly to Rho in the embryonic ven-Recent studies on two proteins, Argos (Aos) and Rhom-
tral midline and may also be involved in the productionboid (Rho), have provided evidence that Egfr can also be
or processing of Spi (Golembo et al., 1996b), a modelregulated via two feedback loops, suggesting that Egfr
that remains to be tested biochemically.itself can regulate its own set of regulators (Figure 1).
rho expression can also be regulated by Egfr. DuringRho Positively Regulates Egfr Signaling. The rho gene
oogenesis, rho expression in follicle cells is expandedencodes an integral membrane protein, is dynamically
in ovaries in which grk gene dosage is increased (re-expressed throughout embryogenesis in a tissue-spe-
viewed by Ray and Schupbach, 1996). rho expressioncific fashion, and exhibits a nearly identical embryonic
is repressed by CF2, a zinc finger transcription factormutant phenotype to spi. Furthermore, rho expression
that is itself repressed by Egfr signaling. Therefore, inis required during development of the wing disc for for-
follicle cells, a feedback loop likely exists whereby Grkmation of distal wing veins (Sturtevant et al., 1993) and
activates Egfr signaling which suppresses CF2 expres-during oogenesis for cell fate specification of antero-
sion, thus allowing rho expression and subsequent Egfrdorsal follicle cells. Gene dosage and genetic interaction
hyperactivation (Hsu et al., 1996). However, such a feed-experiments have revealed stong interactions between
back loop does not appear to exist in all tissues. ForRho and Egfr during wing vein formation. For example,
example, in the embryo the initial zygotic expression ofin animals doubly mutant for gain-of-function alleles of
rho, including expression in the lateral neuroectodermboth rho and Egfr, formation of extra wing veins is en-
and subsequently in the ventral midline is induced byhanced. Conversely, vein loss is greatly enhanced in
Dorsal and Twist and repressed by Snail.animals doubly mutant for loss-of-function alleles of
Aos Negatively Regulates Egfr Signaling. Aos encodesboth rho and Egfr. Together these results suggest that
a secreted protein with a signal sequence, no apparentRho may function to facilitate Egfr signaling (Sturtevant
transmembrane domain and a cysteine-rich region thatet al., 1993).
resembles an EGF motif. Unlike Spi, Vn, and Grk, whichThe expression of rho in the ventral midline of wild-
regulate Egfr positively, Aos, as assessed by in vivotype embryos and its absence in sim mutant embryos
are consistent with its hypothesized role in production genetic interaction studies, inhibits Egfr signaling. For
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example, aos loss-of-function mutations suppress Egfr Egfr signaling could serve only as an on±off switch that
loss-of-function phenotypes, while the aos gain-of- triggers distinct cellular responses in cells with different
function phenotype isenhanced by Egfr loss-of-function histories or prepatterns. In support of this model, several
mutations (Schweitzer et al., 1995b). In vitro, Aos can genes, including orthodenticle (otd), are expressed in
interfere with Egfr activation in a manner that is both distinct D/V domains of the ventral ectoderm prior to
saturable and competitive. Given these latter results and Egfr signaling. When the production of secreted Spi
the fact that Aos contains an EGF domain, it is proposed along the ventral midline is increased, the expression
that Aos acts as an inhibitor of Spi by directly binding pattern of otd is not displaced dorsally (Golembo et al.,
to Egfr (Schweitzer et al., 1995b), a model that remains 1996b) as would be expected if a graded signal triggered
to be demonstrated biochemically. defined threshold responses. This finding suggests that
Interestingly, theexpression of aos isdependent upon ventral ectodermal cells are not equivalent at the time
Egfr activation (Schweitzer et al., 1995b; Golembo et al., they are presented with the midline signal. Thus the
1996a). During embryogenesis, aos expression in the issue of whether the Egfr trigger acts as a morphogen
ventral ectoderm is not observed in Egfr loss-of-function gradient needs to be further substantiated.
mutant embryos. Conversely, in embryos where Egfr is Freeman (1996) has described a similar competition
activated by ectopic expression of secreted Spi, aos between the Aos and Spi signals during eye development.
expression is greatly expanded. Furthermore, two tran- He proposes that the establishment of various cell types
scription factors of the ETS family, PointedP1 (PntP1) in the ommatidium invokes successive waves of recruit-
and Yan, affect aos expression (Gabay et al., 1996). ment by secreted Spi and the secreted inhibitor Aos.
aos is not expressed in pntP1 mutant embryos, and According to this model, active Spi is first produced by
conversely, aos is expressed in cells where PntP1 is the central cells of the ommatidia (R8, R2, and R5) and
ectopically expressed. Together, these results suggest this leads to the recruitment of neighboring cells (R1, R3,
not only that PntP1 is sufficient to positively regulate R4, R6, and R7) as photoreceptors. As cells differentiate
aos expression, but also that it is likely a direct transcrip- they express Aos, which diffuses outward to prevent
tional activator. In embryos mutant for Yan, a negative other cells from activating the Egfr signaling pathway.
regulator of ETS transcriptional activators, aos expres- In summary, studies of Egfr signaling have identified
sion in the ventral ectoderm is expanded, and in a com- proteins that act either positively or negatively to regu-
plementary experiment, expression of an activated form
late receptor activation by specific ligands. These pro-
of Yan greatly reduces expression of aos.
teins can be transcriptionally regulated by Egfr signaling
The Aos Negative Feedback Loop. The fundamental ob-
revealing intricate relationships between the factors that
servation, that transcription of both rho and aos can be
activate the receptor and these feedback loops.
regulated by Egfr itself, demonstrates that this RTK can
Cooperation between Egfr and Sev
activate both negative and positive feedback loops (Fig-
A recent report by Freeman (1996), examining the differ-ure 1). What is the meaning of these intricate relation-
entiation of the R7 photoreceptor cell, describes a situa-ships between activating ligands and feedback loops?
tion whereby activation of two different RTKs, Egfr andWhile the Rho feedback loop during oogenesis requires
Sev, is required for proper establishment of cell fate.further clarification, for Aos, one potential answer is pro-
This unique case, whereby Egfr cooperates with anothervided by studies of patterning of the embryonic ventral
RTK, represents yet an additional mechanism by whichectoderm as well as the ommatidia of the adult eye.
the Egfr can participate in a multitude of developmentalDuring patterning of the embryonic ventral ectoderm,
processes.high levels of Egfr activity induce the most ventral cell
Sev is highly specific to the differentiation of only onefates while lowering activities induce more ventro-lateral
of the eight photoreceptor cells in each ommatidium,cell fates. Golembo et al. (1996b) propose a model
the R7 cell. In a sev mutant, R7 fails to differentiatewhereby graded Egfr activation is established and main-
and instead becomes a lens-secreting cone cell. sev istained by competition between the activating activity of
expressed transiently in 8 of the 20 cells of the ommatid-Spi and the repressing activity of Aos. In the ventral
ium and Sev specificity is regulated by a more localizedmidline, production of Spi, Rho, and S depends on Sim.
signal, the transmembrane protein Boss, which is ex-Rho and S participate in the production or processing
pressed only in R8, a cell that physically touches R7.of Spi from an inactive, membrane form to an active,
In contrast to Sev, Egfr is expressed uniformly in thesecreted form, which then diffuses from the midline,
eye, and clones of Egfr mutant cells are not recoveredpresumably forming a gradient. In cells where Egfr is
in the eye indicating that Egfr is required for cell survival.maximally activated (cells immediately adjacent to the
To circumvent the role of Egfr in cell survival, Freemanmidline), Aos is expressed and secreted, where it, like
(1996) expressed a dominant negative form of Egfr (DN-Spi, diffuses to form a gradient. Along the Aos diffusion
Egfr) in the developing eye after completion of cell prolif-gradient, competition with secreted Spi may result in
eration. In this event loss of Egfr affects determinationeither termination or reduction of Egfr signaling, thus
of all neuronal and nonneuronal cells of the ommatidia,preserving the initial graded effects of Egfr activation.
even in R7 where Sev is required. Realizing that R7Alternatively, the capacity of Aos to block Egfr signaling
development requires both Sev and Egfr, the specificitymay be incomplete. Thus only in the more lateral cells,
of these RTKs was tested. Interestingly, Freeman foundwhere lower levels of Egfr activation are encountered,
that overexpression of activated Egfr in R7 can bypassis Egfr signaling terminated.
the requirement for Sev, indicating that these RTKs haveA second explanation that could account for the ob-
no inherent specificities.servation that different cells fates are determined in the
ventral ectoderm by distinct signaling thresholds is that Why are two RTKs required inR7 for its differentiation?
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One model proposes that, following activation of Egfr Csw (Herbst et al., 1996). Finally, if this model is correct
we are left with a paradox because results of experi-in R7, the sole function of Sev is to further increase the
ments in the eye have argued that Sev and Egfr havelevel of MAPK activation in the cell. Such a scenario
similar specificities. Thus, proteins such as SHP-2 maywould be reminiscent of the observation in PC12 cells
not contribute to RTK specificity per se but may alterna-that different levels and durations of MAPK activation
tively serve to facilitate or amplify signals.lead to different cell fate outcomes (Traverse et al., 1994).
PerspectivesMechanistically, both Egfr and Sev activation would be
We have discussed some of the mechanisms that canrequired to reach a sufficiently high level of MAPK activa-
regulate the activity of the Egfr in Drosophila. However,tion to trigger R7-specific genes. Since both Egfr and
from studies of this receptor in other species, additionalSev appear to regulate similar downstream events, this
mechanisms that modulate the activity of this proteincombinatorial model would explain why upregulation
have been identified and may also play a role in Egfrof Egfr activity can bypass the requirement for Sev.
regulation. Among these are the regulation of RTK activ-Freeman argues that this is unlikely because the
ity by endocytosis, control of receptor turnover, subcel-strength of RTK signaling does not appear to regulate
lular localization of the RTK within the membrane, andthe choice of cell fates in the eye. Instead, he favors a
cross-talk with other signaling pathways.second model whereby both RTKs are required tempo-
A detailed understanding of RTK regulatory mecha-rally in R7. According to this model, R7 differentiation
nisms may have important therapeutic applications.requires two separate bursts of Ras activation, an early
Many cancers are caused by misregulation of RTK path-one triggered by Egfr and a later one triggered by Sev.
ways, and some of the strategies to design drugs thatRole of SHP-2/Csw in RTK Signaling
cure malignancies have focused on targeting drugsSo far, this review has focused on the modulation of
against components of the RTK conserved signalingEgfr activity at extracellular and membrane levels. In
cassette, such as p21ras. However, because these mole-addition, it is possible that specific cytoplasmic signal
cules are shared by multiple RTKs, it may be difficulttransducers of RTKs exist. In the case of Egfr, one such
to achieve specific therapeutic effects. An alternative
example may be the nonreceptor protein tyrosine phos-
strategy is the design of drugs that interfere with the
phatase SHP-2/Corkscrew (Csw). Csw has been impli-
activities of molecules, such as Aos, Rho, and S, that
cated in multiple RTK signaling pathways, including the
function in modulating specific RTK signaling pathways.
Tor, Egfr, and Sev pathways (Allard et al., 1996; Perkins
et al., 1996). Collectively, these studies have led to the Selected Reading
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